Advances and Future Directions in the Treatment of Hepatocellular Carcinoma

Ashil J. Gosalia, MD, Paul Martin, MD, and Patricia D. Jones, MD, MSCR

  Abstract: Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related deaths worldwide. Liver transplant is considered the gold standard for curative therapy for HCC […]

An Overview of Achalasia and Its Subtypes

Dhyanesh A. Patel, MD, Brian M. Lappas, MD, and Michael F. Vaezi, MD, PhD

  Abstract: Achalasia is one of the most studied esophageal motility disorders. However, the pathophysiology and reasons that patients develop achalasia are still unclear. Patients often […]

Occurrence and Recurrence of Hepatocellular Carcinoma After Successful Direct-Acting Antiviral Therapy for Patients With Chronic Hepatitis C Virus Infection

Sirisha Grandhe, MD, and Catherine T. Frenette, MD

  Abstract: Chronic hepatitis C virus (HCV) infection has generally been associated with a slightly increased risk of developing hepatocellular carcinoma (HCC). For the past several […]

Vaccination of Patients With Inflammatory Bowel Disease

Francis A. Farraye, MD, MSc

  G&H  How does the vaccination rate in patients with inflammatory bowel disease compare with that of the general population? FF  Vaccination rates in patients with […]

Peroral Endoscopic Myotomy for the Management of Esophageal Disorders

Ian S. Grimm, MD

  G&H  What is the evolution of peroral endoscopic myotomy as a treatment option for esophageal disorders? IG  The evolution of peroral endoscopic myotomy (POEM) involved […]

The Effect of Digital Health Technology on Patient Care and Research

Christopher V. Almario, MD, MSHPM

  G&H  What is the current state of digital health? CA  Compared to the advances in technology outside of health care, digital health has lagged behind […]

Treatment of Alcoholic Liver Disease

Timothy R. Morgan, MD

  G&H  What are the conditions that constitute alcoholic liver disease? TM  Alcoholic liver disease has a broad clinical spectrum, from mild disease to severe, life-threatening […]

Serous Microcystic Adenoma of the Pancreas

Diego Vázquez Saldaña, MD, David Antonio Mateo de Acosta Andino, MD, and Juan Pablo Gurria, MD

  Cystic pancreatic neoplasms represent approximately 15% of all pancreatic tumors.1 Serous microcystic adenomas account for up to 25% of cystic pancreatic neoplasms and 1% of […]

Letter From the Editor: Achalasia

Gary R. Lichtenstein, MD, AGAF, FACP, FACG

The esophageal motility disorder of achalasia was first described and treated by Sir Thomas Willis in 1672. Treatment consisted of dilation using a sponge attached to […]

Back to Archive
Millennium Medical Publishing, Inc